Ignacio Guerrero-Ros, Ph.D.

Biomedical Researcher | Immunologist I Science Communicator | Medical Writer (@BioSpace)| a 🇪🇸 traveler in search for adventure

[Ignacio Guerrero-Ros, Ph.D. @ItachoGR]

If I could send a letter to my younger self, offering some advice about my professional future, this is how it would look.

Check out my latest article in @biospace about transitioning from #academia to the #healthcare #industry

https://t.co/xU9SfHvDQd

[Russo Partners @russopartners]

How do biotech stories make it from lab to headline? @Solomonswisdom talks with @h_m_mac of @BioSpace & @BenGlickman of @WSJ on what earns trust, builds clarity & gets your story noticed.

🎙️ Listen now: https://t.co/09diAH7ZDP
🎧 Apple Podcasts: https://t.co/Sjd6XJ9qhV
🎥 YouTube: https://t.co/VlnzX6AmFD

#Biotech #MediaRelations #LifeSciences

[Crystalys_Tx @Crystalys_Tx]

Crystalys is announcing its launch with a $205 million Series A financing to support the advancement of Phase 3 clinical studies evaluating lead asset, dotinurad, a next-generation, once daily oral, URAT1 inhibitor for the treatment of gout.

For more: https://t.co/tN7R7MqQr3

[Russo Partners @russopartners]

On the Russo Edge Podcast, Mark Kendall of @WearOptimo explores how microwearables deliver real-time #hydration data:
💧 Personalized health, powered by research
📈 Instant hydration insights
🌎 Versatile for any environment

Check out the episode now!
🎙️ Listen now: https://t.co/ehBox9s0FO
🎧 Apple Podcasts: https://t.co/23MfEf442n
🎥 YouTube: https://t.co/9GUl1clzIN

#Medtech #Wearables

[Russo Partners @russopartners]

What happens when memory fades, but hope remains? 🌿🧠

Muffy Walker, @MuffyW22855, shares how caregiving, trauma, and resilience shaped her novel Memory Weavers—and why these stories matter.

Listen now: https://t.co/ZwsVKLbcTZ
🎧 Apple Podcasts: https://t.co/qlFmGaMJVl
�� YouTube: https://t.co/15poAhjwSx

#MentalHealth #Caregiving #MemoryLoss #Resilience

[LifeSci Advisors @LifeSciAdvisors]

Join @NervgenP $NGEN $NGENF management for a virtual investor event on Apr. 9 at 10:00am ET with Drs. Monica Perez & Steven Kirshblum, who’ll discuss the unmet medical need and current treatment landscape for individuals with spinal cord injury.

Register: https://t.co/BthVDfoQHh

[Zevra Therapeutics @zevratx]

.@Zevratx reports full year 2024 and fourth quarter financial results and provides corporate updates.

Join our webinar discussion at 4:30 p.m. ET: https://t.co/1frOfgUui5

Find the full release here: https://t.co/UUNH2ErYf8

$ZVRA #IR

[Russo Partners @russopartners]

🎧 How is NeuroSense tackling ALS?

On the latest Russo Edge Podcast, @SolomonsWisdom of @russopartners talks with Dr. Shiran Zimri of @NeurosenseT about PrimeC, a novel combination therapy designed to target multiple ALS pathways.

Listen now: https://t.co/OuIfrSYcol
Apple Podcasts: https://t.co/rHRG9K5GMF
Watch on YouTube: https://t.co/OLziEmgoGN

#ALS

[Russo Partners @russopartners]

🎧 On the latest episode of the Russo Edge Podcast, host @SolomonsWisdom of @RussoPartners interviews Kevin Caldwell, CEO of @OssiumHealth, to discuss the company’s groundbreaking approach to bone marrow transplants and its impact on patients.

To listen: https://t.co/pxaZvrr9lG
On Apple Podcasts: https://t.co/GJBtGQjcVF
Watch on YouTube: https://t.co/PyXOYOldUu

#Biopharma #Transplants

[Russo Partners @russopartners]

🎧 On the latest episode of the Russo Edge Podcast, @SolomonsWisdom of @RussoPartners interviews @GayleneX, founder and President of @LabtoLeader. Hear about her insights into the best strategies for life science CEOs. https://t.co/lQq4K5z4qe

YouTube: https://t.co/oCXZAOge15

[AbbVie @abbvie]

NEWS: We announced the acquisition of @aliadatx in a pivotal move to strengthen our #neuroscience portfolio, with the goal of accelerating the development of novel therapies for neurological disorders like Alzheimer’s disease. Learn more: https://t.co/02kU0nmHxE

[Russo Partners @russopartners]

🎧 @SolomonsWisdom of @RussoPartners chats with Dr. Graig Suvannavejh of @MizuhoAmericas for his expert insight into what investments will look like at the end of this year.

To listen: https://t.co/jOuKiMA09g
YouTube: https://t.co/UfTA1qorsi

#Investors #InvestorPodcast

[Oren Gilad Ph.D. @DrOrenGilad]

I enjoyed speaking with Ira Pastor of @ProgressPotent1 about how we are harnessing the DNA damage response to develop targeted therapies against cancer.

Listen now: https://t.co/5neabNl073

[Russo Partners @russopartners]

In this @RussoPartners' Conversations that Matter video, @FibroBiologics CEO Pete O'Heeron discusses the importance of rigorous science and staying focused, even when facing challenges.

#RegenerativeMedicine #ChronicDisease #Science

[Triumvira Immunologics @Triumvirainc]

Our proprietary #TACT #TCell Antigen Coupler technology works directly with the T cell receptor, helping T cells recognize and attack cancer cells through their natural control and feedback mechanisms.

Learn more: https://t.co/tafza8SRAs

#CancerResearch #Oncology

[Alex Knapp @TheAlexKnapp]

There's a whole lot happening in the world of healthcare this week that @katiedjennings and I are working to digest for this week's InnovationRx newsletter. Be sure to subscribe if you haven't already so you don't miss it this afternoon!

https://t.co/IoGZtXUbI3

[Ignacio Guerrero-Ros, Ph.D. @ItachoGR]

Check out the first episode of our @russopartners #podcast #RussoEdge and stay tuned for more interesting #science stories!

[Russo Partners @russopartners]

In the first episode of the @RussoPartners podcast, Russo Edge, host @SolomonsWisdom talks with Dr. Scott Sigman about innovations in knee and shoulder care and how treating pro athletes informs everyday practice.

🎧 Listen: https://t.co/WrbUJApEFr
Apple: https://t.co/TTH4fCMTm1

[Russo Partners @russopartners]

🎙️ @SolomonsWisdom of @RussoPartners chats with Scott Sigman MD from Spire Orthopedic and The Ortho Show about his role in treating high-profile athletes. Hear about the latest innovations in knee and shoulder surgery on the Russo Edge Podcast. https://t.co/c4yg140m9H

[Aprea Therapeutics (NASDAQ: APRE) @ApreaTX]

In a recent @PharmExec feature by @PharmexecM, Oren Gilad of Aprea Therapeutics explains how synthetic lethality targets #cancer's genetic mutations, aiming for effective treatment with fewer side effects. https://t.co/BUpGQJWlXG $APRE #CancerResearch #PrecisionMedicine

[Ignacio Guerrero-Ros, Ph.D. @ItachoGR]

This is a simulation of how space elevators will look.#space #life #cosm... https://t.co/Rz8O789aFt via @YouTube